Cargando…

Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists

[Image: see text] A series of benzyloxy and phenoxy derivatives of the adenosine receptor agonists N(6)-cyclopentyl adenosine (CPA) and N(6)-cyclopentyl 5′-N-ethylcarboxamidoadenosine (CP-NECA) were synthesized, and their potency and selectivity were assessed. We observed that the most potent were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Preti, Barbara, Suchankova, Anna, Deganutti, Giuseppe, Leuenberger, Michele, Barkan, Kerry, Manulak, Iga, Huang, Xianglin, Carvalho, Sabrina, Ladds, Graham, Lochner, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661479/
https://www.ncbi.nlm.nih.gov/pubmed/36270633
http://dx.doi.org/10.1021/acs.jmedchem.2c01414
_version_ 1784830487207870464
author Preti, Barbara
Suchankova, Anna
Deganutti, Giuseppe
Leuenberger, Michele
Barkan, Kerry
Manulak, Iga
Huang, Xianglin
Carvalho, Sabrina
Ladds, Graham
Lochner, Martin
author_facet Preti, Barbara
Suchankova, Anna
Deganutti, Giuseppe
Leuenberger, Michele
Barkan, Kerry
Manulak, Iga
Huang, Xianglin
Carvalho, Sabrina
Ladds, Graham
Lochner, Martin
author_sort Preti, Barbara
collection PubMed
description [Image: see text] A series of benzyloxy and phenoxy derivatives of the adenosine receptor agonists N(6)-cyclopentyl adenosine (CPA) and N(6)-cyclopentyl 5′-N-ethylcarboxamidoadenosine (CP-NECA) were synthesized, and their potency and selectivity were assessed. We observed that the most potent were the compounds with a halogen in the meta position on the aromatic ring of the benzyloxy- or phenoxycyclopentyl substituent. In general, the NECA-based compounds displayed greater A(1)R selectivity than the adenosine-based compounds, with N(6)-2-(3-bromobenzyloxy)cyclopentyl-NECA and N(6)-2-(3-methoxyphenoxy)cyclopentyl-NECA showing ∼1500-fold improved A(1)R selectivity compared to NECA. In addition, we quantified the compounds’ affinity and kinetics of binding at both human and rat A(1)R using a NanoBRET binding assay and found that the halogen substituent in the benzyloxy- or phenoxycyclopentyl moiety seems to confer high affinity for the A(1)R. Molecular modeling studies suggested a hydrophobic subpocket as contributing to the A(1)R selectivity displayed. We believe that the identified selective potent A(1)R agonists are valuable tool compounds for adenosine receptor research.
format Online
Article
Text
id pubmed-9661479
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-96614792022-11-15 Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists Preti, Barbara Suchankova, Anna Deganutti, Giuseppe Leuenberger, Michele Barkan, Kerry Manulak, Iga Huang, Xianglin Carvalho, Sabrina Ladds, Graham Lochner, Martin J Med Chem [Image: see text] A series of benzyloxy and phenoxy derivatives of the adenosine receptor agonists N(6)-cyclopentyl adenosine (CPA) and N(6)-cyclopentyl 5′-N-ethylcarboxamidoadenosine (CP-NECA) were synthesized, and their potency and selectivity were assessed. We observed that the most potent were the compounds with a halogen in the meta position on the aromatic ring of the benzyloxy- or phenoxycyclopentyl substituent. In general, the NECA-based compounds displayed greater A(1)R selectivity than the adenosine-based compounds, with N(6)-2-(3-bromobenzyloxy)cyclopentyl-NECA and N(6)-2-(3-methoxyphenoxy)cyclopentyl-NECA showing ∼1500-fold improved A(1)R selectivity compared to NECA. In addition, we quantified the compounds’ affinity and kinetics of binding at both human and rat A(1)R using a NanoBRET binding assay and found that the halogen substituent in the benzyloxy- or phenoxycyclopentyl moiety seems to confer high affinity for the A(1)R. Molecular modeling studies suggested a hydrophobic subpocket as contributing to the A(1)R selectivity displayed. We believe that the identified selective potent A(1)R agonists are valuable tool compounds for adenosine receptor research. American Chemical Society 2022-10-21 2022-11-10 /pmc/articles/PMC9661479/ /pubmed/36270633 http://dx.doi.org/10.1021/acs.jmedchem.2c01414 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Preti, Barbara
Suchankova, Anna
Deganutti, Giuseppe
Leuenberger, Michele
Barkan, Kerry
Manulak, Iga
Huang, Xianglin
Carvalho, Sabrina
Ladds, Graham
Lochner, Martin
Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists
title Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists
title_full Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists
title_fullStr Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists
title_full_unstemmed Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists
title_short Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists
title_sort discovery and structure–activity relationship studies of novel adenosine a(1) receptor-selective agonists
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661479/
https://www.ncbi.nlm.nih.gov/pubmed/36270633
http://dx.doi.org/10.1021/acs.jmedchem.2c01414
work_keys_str_mv AT pretibarbara discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists
AT suchankovaanna discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists
AT deganuttigiuseppe discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists
AT leuenbergermichele discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists
AT barkankerry discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists
AT manulakiga discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists
AT huangxianglin discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists
AT carvalhosabrina discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists
AT laddsgraham discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists
AT lochnermartin discoveryandstructureactivityrelationshipstudiesofnoveladenosinea1receptorselectiveagonists